2CB-Ind

2CB-Ind
Clinical data
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	In general: uncontrolled;
Identifiers
	IUPAC name (5-bromo-4,7-dimethoxy-2,3-dihydro-1H-inden-1-yl)methanamine;
CAS Number	912342-23-5 ;
PubChem CID	16086368;
ChemSpider	17245022 ;
UNII	ZMP92SN5X2;
ChEMBL	ChEMBL424890 ;
CompTox Dashboard (EPA)	DTXSID70582080 ;
Chemical and physical data
Formula	C12H16BrNO2
Molar mass	286.169 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COc1c(Br)cc(OC)c2c1CCC2CN;
	InChI InChI=1S/C12H16BrNO2/c1-15-10-5-9(13)12(16-2)8-4-3-7(6-14)11(8)10/h5,7H,3-4,6,14H2,1-2H3 ; Key:HCLPGYNQMVSQIM-UHFFFAOYSA-N ;
	(what is this?) (verify)

2CB-Ind is a conformationally-restricted derivative of the phenethylamine hallucinogen 2C-B, discovered in 1974 by Alexander Shulgin. It acts as a moderately potent and selective agonist for the 5-HT_2A and 5-HT_2C receptors, but unlike the corresponding benzocyclobutene derivative TCB-2 which is considerably more potent than the parent compound 2C-B, 2CB-Ind is several times weaker, with racemic 2CB-Ind having a K_i of 47nM at the human 5-HT_2A receptor, only slightly more potent than the mescaline analogue (R)-jimscaline.^[1]^[2]

Quick Facts Clinical data, Routes ofadministration ...

[1]

[2]

2CB-Ind

Analogues and derivatives

See also

References

Wikiwand - on